Rahul Palchaudhuri

Person

Somerville, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Compositions and methods for the depletion of CD117+ cells
- Patent number 11,958,908
- Issue date Apr 16, 2024
- CRISPR THERAPEUTICS AG
- Bradley R. Pearse
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD117 antibodies and conjugates
- Patent number 11,572,411
- Issue date Feb 7, 2023
- Magenta Therapeutics, Inc.
- Bradley R. Pearse
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for the depletion of CD117+ cells
- Patent number 10,899,843
- Issue date Jan 26, 2021
- Magenta Therapeutics, Inc.
- Bradley R. Pearse
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for the depletion of CD117+ cells
- Patent number 10,882,915
- Issue date Jan 5, 2021
- Magenta Therapeutics, Inc.
- Bradley R. Pearse
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for the depletion of CD137+ cells
- Patent number 10,576,161
- Issue date Mar 3, 2020
- Magenta Therapeutics, Inc.
- Adam Hartigan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for the depletion of CD137+ cells
- Patent number 10,434,185
- Issue date Oct 8, 2019
- Magenta Therapeutics, Inc.
- Adam Hartigan
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD117+ CELLS
- Publication number 20240360238
- Publication date Oct 31, 2024
- CRISPR Therapeutics AG
- Bradley R. Pearse
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FC SILENCED ANTIBODY DRUG CONJUGATES (ADCS) AND USES THEREOF
- Publication number 20240075157
- Publication date Mar 7, 2024
- Magenta Therapeutics, Inc.
- Anthony Boitano
- C07 - ORGANIC CHEMISTRY
Information Patent Application
T-CELL BISPECIFIC BINDING PROTEINS
- Publication number 20230183344
- Publication date Jun 15, 2023
- Magenta Therapeutics, Inc.
- Rahul Palchaudhuri
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD45 ANTIBODIES AND CONJUGATES THEREOF
- Publication number 20220267441
- Publication date Aug 25, 2022
- Magenta Therapeutics, Inc.
- Anthony Boitano
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD117 ANTIBODIES AND USES THEREOF
- Publication number 20220177578
- Publication date Jun 9, 2022
- Magenta Therapeutics, Inc.
- Rahul Palchaudhuri
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-CD45 Antibody Drug Conjugates and Uses Thereof
- Publication number 20220175951
- Publication date Jun 9, 2022
- Magenta Therapeutics, Inc.
- Anthony Boitano
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD117 ANTIBODIES AND USES THEREOF
- Publication number 20220177575
- Publication date Jun 9, 2022
- Magenta Therapeutics, Inc.
- Rahul Palchaudhuri
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CONDITIONING METHODS FOR GENE THERAPY
- Publication number 20220175946
- Publication date Jun 9, 2022
- Magenta Therapeutics, Inc.
- Anthony BOITANO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
- Publication number 20210379195
- Publication date Dec 9, 2021
- Magenta Therapeutics, Inc.
- Rahul Palchaudhuri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD45 ANTIBODIES AND CONJUGATES THEREOF
- Publication number 20210371524
- Publication date Dec 2, 2021
- Magenta Therapeutics, Inc.
- Rahul Palchaudhuri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD5+ CELLS
- Publication number 20210369854
- Publication date Dec 2, 2021
- Magenta Therapeutics, Inc.
- Anthony Boitano
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD117+ CELLS
- Publication number 20210317228
- Publication date Oct 14, 2021
- Magenta Therapeutics, Inc.
- Bradley R. Pearse
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD117+ CELLS
- Publication number 20210206872
- Publication date Jul 8, 2021
- Magenta Therapeutics, Inc.
- Bradley R. Pearse
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FC SILENCED ANTIBODY DRUG CONJUGATES (ADCS) AND USES THEREOF
- Publication number 20200376135
- Publication date Dec 3, 2020
- Magenta Therapeutics, Inc.
- Anthony Boitano
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD2+ CELLS
- Publication number 20200368363
- Publication date Nov 26, 2020
- MAGENTA THEERAPEUTICS, INC.
- Anthony BOITANO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD137+ CELLS
- Publication number 20200289664
- Publication date Sep 17, 2020
- Magenta Therapeutics, Inc.
- Adam Hartigan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD5+ CELLS
- Publication number 20200276326
- Publication date Sep 3, 2020
- Magenta Therapeutics, Inc.
- Anthony Boitano
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FC SILENCED ANTIBODY DRUG CONJUGATES (ADCS) AND USES THEREOF
- Publication number 20200255523
- Publication date Aug 13, 2020
- Magenta Therapeutics, Inc.
- Rahul Palchaudhuri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD117+ CELLS
- Publication number 20190153114
- Publication date May 23, 2019
- Magenta Therapeutics, Inc.
- Bradley R. Pearse
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD117+ CELLS
- Publication number 20190144558
- Publication date May 16, 2019
- Magenta Therapeutics, Inc.
- Bradley R. Pearse
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD137+ CELLS
- Publication number 20190076548
- Publication date Mar 14, 2019
- Magenta Therapeutics, Inc.
- Adam Hartigan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD137+ CELLS
- Publication number 20180289832
- Publication date Oct 11, 2018
- Magenta Therapeutics, Inc.
- Adam Hartigan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Rahul Palchaudhuri

Person

Patents Grantslast 30 patents

Compositions and methods for the depletion of CD117+ cells

Anti-CD117 antibodies and conjugates

Compositions and methods for the depletion of CD117+ cells

Compositions and methods for the depletion of CD117+ cells

Compositions and methods for the depletion of CD137+ cells

Compositions and methods for the depletion of CD137+ cells

Patents Applicationslast 30 patents

COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD117+ CELLS

FC SILENCED ANTIBODY DRUG CONJUGATES (ADCS) AND USES THEREOF

T-CELL BISPECIFIC BINDING PROTEINS

ANTI-CD45 ANTIBODIES AND CONJUGATES THEREOF

ANTI-CD117 ANTIBODIES AND USES THEREOF

Anti-CD45 Antibody Drug Conjugates and Uses Thereof

ANTI-CD117 ANTIBODIES AND USES THEREOF

CONDITIONING METHODS FOR GENE THERAPY

METHODS FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

ANTI-CD45 ANTIBODIES AND CONJUGATES THEREOF

COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD5+ CELLS

COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD117+ CELLS

COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD117+ CELLS

FC SILENCED ANTIBODY DRUG CONJUGATES (ADCS) AND USES THEREOF

COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD2+ CELLS

COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD137+ CELLS

COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD5+ CELLS

FC SILENCED ANTIBODY DRUG CONJUGATES (ADCS) AND USES THEREOF

COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD117+ CELLS

COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD117+ CELLS

COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD137+ CELLS

COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD137+ CELLS